Concepedia

Michael B. Ruckle

MB

4

Publications

286

Citations

4

H-Index

2001

Active since

Affiliations

University of Arkansas for Medical Sciences(Current)

Michael B. Ruckle is an author at University of Arkansas for Medical Sciences specializing in cell signaling, opioid overdose, and molecular pharmacology.

Top concepts

Publications per year

2001–2005

4

Publications

4

Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors

Jennifer L. Shoemaker, Michael B. Ruckle, Philip R. Mayeux et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 130 citations

The Endocannabinoid Noladin Ether Acts as a Full Agonist at Human CB2 Cannabinoid Receptors

Jennifer L. Shoemaker, Biny K. Joseph, Michael B. Ruckle et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 78 citations

Constitutively Active μ-Opioid Receptors Inhibit Adenylyl Cyclase Activity in Intact Cells and Activate G-proteins Differently than the Agonist [d-Ala2,N-MePhe4,Gly-ol5]Enkephalin

Jing‐Gen Liu, Michael B. Ruckle, Paul L. Prather · Journal of Biological Chemistry · 2001 · 52 citations · Full text

, , +19

Agonist, Antagonist, and Inverse Agonist Characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a Selective δ-Opioid Receptor Ligand

Nancy A. Martin, Michael B. Ruckle, Stephanie L VanHoof et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 26 citations · Full text

Rows per page

1–4 of 4